AFG
GSK icon

Atomi Financial Group’s GSK GSK Stock Holding History

Atomi Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
38,743
-255
-0.7% -$13.5K 0.05% 262
2026
Q1 		$2.15M Buy
38,998
+1,012
+3% +$54.8K 0.07% 231
2025
Q4 		$1.86M Buy
37,986
+11,502
+43% +$536K 0.05% 256
2025
Q3 		$1.14M Buy
26,484
+2,506
+10% +$97.9K 0.04% 336
2025
Q2 		$921K Sell
23,978
-1,176
-5% -$44.9K 0.03% 364
2025
Q1 		$974K Buy
25,154
+11,664
+86% +$427K 0.04% 315
2024
Q4 		$456K Sell
13,490
-2,273
-14% -$81.8K 0.02% 518
2024
Q3 		$644K Buy
15,763
+1,531
+11% +$62.6K 0.04% 363
2024
Q2 		$548K Buy
14,232
+1,516
+12% +$63.8K 0.04% 365
2024
Q1 		$545K Buy
12,716
+2,738
+27% +$113K 0.05% 321
2023
Q4 		$370K Buy
+9,978
New +$358K 0.05% 349

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Atomi Financial Group's GSK Position: Q2 2026 in Review

Atomi Financial Group reduced its GSK (GSK) stake by 0.65% in Q2 2026, selling an estimated $13.5K and leaving 38,743 shares worth $2.03M. The position accounts for 0.05% of the portfolio, ranked #262.

Atomi Financial Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.15M in Q1 2026. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Atomi Financial Group held 38,743 shares of GSK worth $2.03M as of Q2 2026.
  • Atomi Financial Group sold 255 GSK shares in Q2 2026, an estimated $13.5K.
  • GSK made up 0.05% of Atomi Financial Group's portfolio in Q2 2026, its #262 holding.
  • Atomi Financial Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Atomi Financial Group's GSK position peaked at $2.15M in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.